11/13/24 17:35 | 11/11/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S | -1,669 | 55.62 | 0 | -30 | -10 | 282 | D | | | | | | | | | | | | | | |
10/15/24 18:00 | 10/13/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 8 | 3 | 312 | D | | | | | | | | | | | | | | |
10/15/24 18:00 | 10/14/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -199 | 46.28 | 0 | -4 | -1 | 312 | D | | | | | | | | | | | | | | |
4/17/24 17:45 | 4/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 374 | 19.12 | 0 | 20 | 5 | 408 | D | | | | | | | | | | | | | | |
4/17/24 17:45 | 4/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,173 | 59.91 | 0 | -20 | -5 | 408 | D | | | | | | | | | | | | | | |
3/18/24 17:45 | 3/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 382 | 19.12 | 0 | 20 | 5 | 408 | D | | | | | | | | | | | | | | |
3/18/24 17:45 | 3/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,450 | 72.48 | 0 | -20 | -5 | 408 | D | | | | | | | | | | | | | | |
3/12/24 17:45 | 3/10/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 0 | 0.00 | 0 | 28 | 7 | 408 | D | | | | | | | | | | | | | | |
3/12/24 17:45 | 3/11/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.dm | -1,108 | 77.04 | 0 | -14 | -3 | 408 | D | | | | | | | | | | | | | | |
2/21/24 17:45 | 2/18/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 13 | 3 | 394 | D | | | | | | | | | | | | | | |
2/21/24 17:45 | 2/20/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -507 | 79.67 | 0 | -6 | -2 | 394 | D | | | | | | | | | | | | | | |
2/16/24 17:45 | 2/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 382 | 19.12 | 0 | 20 | 5 | 387 | D | | | | | | | | | | | | | | |
2/16/24 17:45 | 2/15/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,607 | 80.36 | 0 | -20 | -5 | 387 | D | | | | | | | | | | | | | | |
1/31/24 17:45 | 1/29/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 956 | 19.12 | 0 | 50 | 15 | 387 | D | | | | | | | | | | | | | | |
1/31/24 17:45 | 1/29/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -3,026 | 60.51 | 0 | -50 | -11 | 387 | D | | | | | | | | | | | | | | |
1/18/24 17:45 | 1/16/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 382 | 19.12 | 0 | 20 | 5 | 387 | D | | | | | | | | | | | | | | |
1/18/24 17:45 | 1/16/24 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,250 | 62.50 | 0 | -20 | -5 | 387 | D | | | | | | | | | | | | | | |
6/1/23 17:44 | 5/30/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 387 | D | | | | | | | | | | | | | | |
6/1/23 17:44 | 5/30/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,622 | 64.88 | 0 | -25 | -6 | 387 | D | | | | | | | | | | | | | | |
4/27/23 17:37 | 4/25/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 387 | D | | | | | | | | | | | | | | |
4/27/23 17:37 | 4/25/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,267 | 50.67 | 0 | -25 | -6 | 387 | D | | | | | | | | | | | | | | |
3/31/23 17:49 | 3/29/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 387 | D | | | | | | | | | | | | | | |
3/31/23 17:49 | 3/29/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,112 | 44.46 | 0 | -25 | -6 | 387 | D | | | | | | | | | | | | | | |
3/14/23 17:47 | 3/10/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 0 | 0.00 | 0 | 21 | 6 | 387 | D | | | | | | | | | | | | | | |
3/1/23 18:11 | 2/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 376 | D | | | | | | | | | | | | | | |
3/1/23 18:11 | 2/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,206 | 48.25 | 0 | -25 | -6 | 376 | D | | | | | | | | | | | | | | |
2/22/23 17:38 | 2/18/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 13 | 4 | 376 | D | | | | | | | | | | | | | | |
1/31/23 17:34 | 1/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 369 | D | | | | | | | | | | | | | | |
1/31/23 17:34 | 1/27/23 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,287 | 51.47 | 0 | -25 | -6 | 369 | D | | | | | | | | | | | | | | |
12/30/22 17:33 | 12/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 7 | 369 | D | | | | | | | | | | | | | | |
12/30/22 17:33 | 12/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,023 | 40.93 | 0 | -25 | -6 | 369 | D | | | | | | | | | | | | | | |
12/8/22 17:35 | 12/6/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 105 | 1.81 | 0 | 58 | 19 | 369 | D | | | | | | | | | | | | | | |
12/6/22 17:49 | 12/3/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 40 | 15 | 311 | D | | | | | | | | | | | | | | |
11/30/22 17:36 | 11/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 478 | 19.12 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
11/30/22 17:36 | 11/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,351 | 54.03 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
10/28/22 17:43 | 10/26/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 421 | 16.84 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
10/28/22 17:43 | 10/26/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,370 | 54.81 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
9/30/22 17:42 | 9/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 405 | 16.21 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
9/30/22 17:42 | 9/28/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,615 | 64.61 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
8/31/22 17:45 | 8/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 405 | 16.21 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
8/31/22 17:45 | 8/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,671 | 66.84 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
7/29/22 17:38 | 7/27/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 375 | 15.00 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
7/29/22 17:38 | 7/27/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,898 | 75.91 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
7/1/22 18:00 | 6/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 314 | 12.57 | 0 | 25 | 9 | 290 | D | | | | | | | | | | | | | | |
7/1/22 18:00 | 6/29/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,540 | 61.59 | 0 | -25 | -8 | 290 | D | | | | | | | | | | | | | | |
3/14/22 18:12 | 3/10/22 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 0 | 0.00 | 0 | 21 | 8 | 290 | D | | | | | | | | | | | | | | |
12/22/21 20:00 | 12/20/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 32 | 1.81 | 0 | 18 | 7 | 279 | D | | | | | | | | | | | | | | |
12/7/21 20:00 | 12/3/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 80 | 44 | 261 | D | | | | | | | | | | | | | | |
10/18/21 20:00 | 10/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 60 | 1.81 | 0 | 33 | 18 | 220 | D | | | | | | | | | | | | | | |
8/6/21 20:00 | 8/4/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 377 | 12.57 | 0 | 30 | 9 | 375 | D | | | | | | | | | | | | | | |
8/6/21 20:00 | 8/4/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.dm | -3,863 | 128.78 | 0 | -30 | -7 | 375 | D | | | | | | | | | | | | | | |
6/17/21 17:44 | 6/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 377 | 12.57 | 0 | 30 | 19 | 188 | D | | | | | | | | | | | | | | |
6/17/21 17:44 | 6/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -3,793 | 126.43 | 0 | -30 | -14 | 188 | D | | | | | | | | | | | | | | |
3/12/21 17:49 | 3/10/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 0 | 0.00 | 0 | 12 | 7 | 188 | D | | | | | | | | | | | | | | |
1/20/21 18:11 | 1/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 36 | 1.81 | 0 | 20 | 12 | 183 | D | | | | | | | | | | | | | | |
1/20/21 18:11 | 1/15/21 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -4,273 | 213.67 | 0 | -20 | -10 | 183 | D | | | | | | | | | | | | | | |
12/30/20 16:02 | 12/29/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 25 | 1.81 | 0 | 14 | 8 | 183 | D | | | | | | | | | | | | | | |
12/11/20 16:05 | 12/10/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 36 | 1.81 | 0 | 20 | 13 | 169 | D | | | | | | | | | | | | | | |
12/11/20 16:05 | 12/10/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -2,846 | 142.29 | 0 | -20 | -11 | 169 | D | | | | | | | | | | | | | | |
6/3/20 17:32 | 6/1/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 31 | 1.81 | 0 | 17 | 11 | 171 | D | | | | | | | | | | | | | | |
6/3/20 17:32 | 6/1/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,117 | 64.68 | 0 | -17 | -9 | 171 | D | | | | | | | | | | | | | | |
5/21/20 16:35 | 5/19/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.dm | 27 | 1.81 | 0 | 15 | 10 | 172 | D | | | | | | | | | | | | | | |
5/21/20 16:35 | 5/19/20 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.dm | -979 | 65.25 | 0 | -15 | -8 | 172 | D | | | | | | | | | | | | | | |
12/18/19 16:05 | 12/16/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 14 | 1.81 | 0 | 8 | 5 | 172 | D | | | | | | | | | | | | | | |
6/19/19 16:15 | 6/17/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 36 | 1.81 | 0 | 20 | 14 | 166 | D | | | | | | | | | | | | | | |
6/19/19 16:15 | 6/17/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -920 | 46.00 | 0 | -20 | -11 | 166 | D | | | | | | | | | | | | | | |
5/1/19 16:05 | 4/29/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 36 | 1.81 | 0 | 20 | 14 | 167 | D | | | | | | | | | | | | | | |
5/1/19 16:05 | 4/29/19 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -841 | 42.03 | 0 | -20 | -11 | 167 | D | | | | | | | | | | | | | | |
12/11/18 16:29 | 12/7/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 39 | 1.81 | 0 | 22 | 15 | 167 | D | | | | | | | | | | | | | | |
6/5/18 20:20 | 6/1/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | M.d | 27 | 1.81 | 0 | 15 | 11 | 148 | D | | | | | | | | | | | | | | |
6/5/18 20:20 | 6/1/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | DO | CEO | S.d | -1,040 | 69.36 | 0 | -15 | -9 | 148 | D | | | | | | | | | | | | | | |
12/26/17 17:11 | 12/21/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | CEO | M.d | 27 | 1.81 | 0 | 15 | 11 | 149 | D | | | | | | | | | | | | | | |
8/30/17 18:12 | 8/28/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | S.m | -545 | 20.08 | 0 | -27 | -20 | 107 | D | | | | | | | | | | | | | | |
4/28/17 18:13 | 4/26/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | M.dm | 10 | 1.81 | 1 | 5 | 4 | 134 | D | | | 18 | -9 | -17 | -13 | -11 | 3 | 0 | -2 | | | | |
4/28/17 18:13 | 4/26/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | S.dm | -92 | 16.76 | 1 | -5 | -4 | 134 | D | | | 18 | -9 | -17 | -13 | -11 | 3 | 0 | -2 | | | | |
4/25/17 19:36 | 4/21/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | M.dm | 21 | 1.81 | 2 | 12 | 9 | 134 | D | | | 19 | -11 | -22 | -23 | -12 | -6 | -1 | 1 | | | | |
4/25/17 19:36 | 4/21/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | S.dm | -195 | 16.78 | 2 | -12 | -8 | 134 | D | | | 19 | -11 | -22 | -23 | -12 | -6 | -1 | 1 | | | | |
4/21/17 16:32 | 4/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | M.dm | 18 | 1.81 | 1 | 10 | 8 | 134 | D | | | | -18 | -19 | -17 | -8 | -13 | -2 | 0 | | | | |
4/21/17 16:32 | 4/19/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Kulkarni Samarth | MA | O | Chief Bu | S.dm | -178 | 17.73 | 1 | -10 | -7 | 134 | D | | | | -18 | -19 | -17 | -8 | -13 | -2 | 0 | | | | |